Health

  • The Great Restoration: From Slowing Aging to Epigenetic Rejuvenation

    For decades, geroscience was synonymous with “damage limitation.” In 2026, the paradigm has shifted toward cellular reprogramming. Based on the Information Theory of Aging, we now understand that aging is not the loss of information (DNA damage), but the loss of the ability to read it (epigenetic noise). This article explores the clinical launch of Yamanaka Factor therapies, the role of DNA Methylation Clocks in validating biological age reversal, and the emergence of autologous bio-banking as the ultimate insurance policy for the 2030s.

  • The Mitochondrial Battery: Decoding the Science of Near-Infrared Photobiomodulation

    While nutrition and exercise dominate health discourse, the bio-energetic impact of light remains largely overlooked. Humans have evolved under a solar spectrum rich in Near-Infrared (NIR) light, yet modern life is spent under narrow-spectrum LED and fluorescent lighting. This article explores the mechanism of Cytochrome c Oxidase—the primary photoreceptor in our cells—and how specific wavelengths between $660\text{ nm}$ and $850\text{ nm}$ can upregulate ATP production, reduce localized oxidative stress, and act as a systemic “metabolic primer.”

  • Beyond Vitamin D: The Mechanistic Shift Toward Senolytics and NAD+ Precursors

    The “Supplement Era” is transitioning into the “Intervention Era.” We are moving away from broad-spectrum multivitamins—which often lack bioavailability—toward targeted molecular interventions. This article examines the pathways of AMPK activation, Sirtuin regulation, and the clearance of Senescent (“Zombie”) Cells. By understanding the rate-limiting steps in cellular repair, we can move from reactive supplementation to proactive genomic maintenance.

  • The Glycemic Variability Factor: Why “Normal” Blood Sugar is an Incomplete Metric

    Standard medical screenings focus on HbA1c—an average of blood glucose over 90 days. However, emerging research suggests that “Average” is a dangerous mask. Glycemic Variability (GV)—the frequency and intensity of glucose “spikes” and “crashes”—is a more potent predictor of oxidative stress, mitochondrial dysfunction, and vascular inflammation than mean glucose levels alone. This article examines the physiological cost of postprandial glucose excursions and the technical strategies for flattening the curve.